Brief: Quanterix And Akoya Biosciences Announce Amended Merger Agreement
April 29 (Reuters) - Akoya Biosciences Inc AKYA.O: QUANTERIX AND AKOYA BIOSCIENCES ANNOUNCE AMENDED MERGER AGREEMENT QUANTERIX CORP - AKOYA SHAREHOLDERS TO RECEIVE $0.38 CASH AND 0.1461 QUANTERIX SHARES QUANTERIX CORP: UNDER AMENDED TERMS, CO WILL ISSUE ABOUT 7.76 MILLION SHARES OF ITS COMMON STOCK AND PAY $20 MILLION IN CASH TO AKOYA SHAREHOLDERS Source text: ID:nBw5n9gBha Further company coverage: AKYA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quanterix
See all newsBrief: Alzpath And Quanterix Expand Strategic Licensing Agreement To Advance Next Generation Alzheimer's Disease Biomarker Research
Quanterix Corporation reports results for the quarter ended June 30 - Earnings Summary
Quanterix Q2 revenue rises 34% but cuts 2026 outlook
Quanterix Corporation expected to post a loss of 46 cents a share - Earnings Preview
Quanterix Corp expected to post a loss of 46 cents a share - Earnings Preview